VEGF Levels in Smokers with COPD
Author Information
Author(s): Rovina Nikoletta, Papapetropoulos Andreas, Kollintza Androniki, Michailidou Makrina, Simoes Davina CM, Roussos Charis, Gratziou Christina
Primary Institution: Asthma and Allergy Center, Pulmonary and Critical Care Department, Evgenidion Hospital, Medical School, University of Athens, Greece
Hypothesis
Is smoking a potential cause of raised airway VEGF levels in bronchitis type COPD?
Conclusion
VEGF levels are raised in the airways of both asymptomatic and COPD smokers, indicating its role as a marker of airway inflammation.
Supporting Evidence
- VEGF levels were significantly higher in COPD patients compared to non-smokers and asymptomatic smokers.
- Significant correlations were found between VEGF levels and pack years, IL-8, and TNF-α levels.
- No correlation was found between VEGF levels and pulmonary function parameters.
Takeaway
This study found that smoking increases a substance called VEGF in the lungs, which is linked to inflammation, even in people who don't have breathing problems yet.
Methodology
The study measured VEGF, IL-8, and TNF-α levels in induced sputum from current smokers with COPD, asymptomatic smokers, and non-smokers.
Potential Biases
Potential selection bias due to the specific criteria for participant inclusion.
Limitations
The study focused on a specific group of smokers and may not generalize to all COPD patients.
Participant Demographics
14 COPD smokers, 17 asymptomatic smokers, and 16 non-smokers, all matched for age.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website